Drugs / Anti-D
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT00128882 | Nov 2004 → Jan 2008 | autoimmune thrombocytopenic purpura | University of Aarhus | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT00239733 | Mar 2005 → Feb 2010 | HIV infectious disease, hepatitis C virus infection, thrombocytopenia | National Institute of Allergy and Infectious Diseases (NIAID) | Terminated | No outcome recorded Stop: Enrollment |
| Phase not applicable1 trial | ||||||
| — | NCT01443247 | Sep 2010 → Sep 2011 | dengue disease | Post Graduate Institute of Medical Education and Research, Chandigarh | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Anti-D | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00239733 ↗ |
| Route | Subcutaneous | “Subcutaneous injection” NCT00128882 ↗ |